Evidence map›Paper›PMID 39471038›Full record

ArticleAsian Pacific journal of cancer prevention : APJCP2024

Cytotoxic Effect of Stenotrophomonas maltophilia Isolated from Prostate and Bladder Cancer Patients in Iraq.

Enas Ammar, Nada Al-Mudallal, Sura Mouaid Abbas

Abstract read
In one paragraph

Article in Asian Pacific journal of cancer prevention : APJCP, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Investigating the Anticancer Properties of Bacterial Toxoid in Combination Vaccines.Asian Pacific journal of cancer prevention : APJCP · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Enas AmmarAlnukhba University Collage, Medical Laboratory Department, Baghdad, Iraq.
Nada Al-MudallalAl-Iraqia University, College of Medicine, Medical Microbiology Department, Baghdad, Iraq.
Sura Mouaid AbbasDepartment of Biology, College of Science, Al-Mustansiriyah university, Baghdad, Iraq.ORCID 0000-0001-5132-0504

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveThis study investigated the cytotoxic effects of Stenotrophomonas maltophilia on normal human cells.

methodsSeven isolates of S. maltophilia were obtained from 120 urine samples collected from prostate and bladder cancer patients, with diagnoses confirmed via Vitek. The cytotoxicity of these bacterial isolates was assessed on normal human fibrocyte cells (NHF) using various concentrations of bacterial filtrate (3.125, 6.25, 12.5, 25, 50, and 100 μg/ml).

resultsThe bacterial filtrate exhibited significant toxicity to NHF cells, with the highest cell death rate of 68% and the lowest optical density (OD) of 0.25 at a concentration of 100 μg/ml. The IC50 value, indicating the concentration at which 50% inhibition of cell viability occurred, was determined to be 49.35 μg/ml. Further research is necessary to explore the potential role of these bacterial isolates in promoting cancer through inflammation.

conclusionThe clinical isolates of S. maltophilia demonstrated substantial cytotoxic activity against normal human fibrocyte cells, leading to a notable reduction in both cell number and optical density, with the highest percentage of cell death observed. These findings suggest the need for further investigation into the specific toxins or enzymes involved, which could pave the way for future studies.

Indexed as

Prostatic NeoplasmsStenotrophomonas maltophiliaUrinary Bladder NeoplasmsCell ProliferationCell SurvivalGram-Negative Bacterial InfectionsHumansIraqMalebladder cancerCytotoxic activityProstate CancerStenotrophomonas maltophilia

Identifiers

PMID39471038
PMCPMC11711334

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.